Skip to main navigation Skip to search Skip to main content

Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model

  • Ingrid H C H M Philippens
  • , Jacqueline A Wubben
  • , Bente Finsen
  • , Bert A 't Hart
    • Biomedical Primate Research Centre
    • New York Medical College
    • University Medical Center Groningen
    • Erasmus University Medical Center Rotterdam

    Research output: Contribution to journal › Journal article › Research › peer-review

    Fingerprint

    Dive into the research topics of 'Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model'. Together they form a unique fingerprint.
    Sort by

    Pharmacology, Toxicology and Pharmaceutical Science